Foseal 400mg
Available Dosages
| Description | Foseal Sevelamer 400mg |
|---|---|
| SKU | 939 |
| Generic For | Foseal |
| Strength | 400mg |
| Manufacturer | Emcure |
| Active Ingredient | Sevelamer |
Out Of Stock
Foseal 400mg (Sevelamer)
Foseal 400mg
Foseal 400mg is a medicine prescribed to control hyperphosphatemia in adults receiving haemodialysis or peritoneal dialysis. The active ingredient in Foseal tablets is Sevelamer hydrochloride, a phosphate binder meant for oral administration. It is used for the control of serum phosphorous in patients with chronic kidney on dialysis. Sevelamer therapy must be followed with multiple therapeutic approaches, including calcium supplements or 1,25-dihydroxy vitamin D3, to control the development of renal bone disorder.
How to use (infographics and instructions)
Follow your doctor’s advice when it comes to using Foseal 400 mg tablets. Make a call to your doctor if you have any doubt on how and when to take the tablets.
Precautions (warning, allergy, things to remember)
Do not use Foseal 400mg if you are hypersensitive to Sevelamer, have a bowel obstruction, or have hypophosphatemia. Efficacy and safety of this anti-rejection drug have not been studied in patients with:
- Active inflammatory bowel disease
- Swallowing disorders
- Patients with a history of major gastrointestinal surgery
- Gastrointestinal motility disorders including untreated or untreated or severe gastroparesis, irregular bowel motion, and retention of gastric contents. In such cases, patients should exercise caution when Foseal 400 mg tablets.
Intestinal obstruction: Rarely intestinal obstruction has been reported in patients during treatment with Sevelamer hydrochloride. Constipation may be a common symptom. Patients dealing with constipation should be monitored carefully while receiving this phosphate binding drug. The treatment should be re-evaluated in such patients or in those who have other severe gastrointestinal symptoms.
Folate deficiency: At present, there is insufficient data to exclude the possibility of folate deficiency during prolonged use.
Hypercalcaemia/hypocalcaemia: Patients suffering from renal disorder may develop hypercalcaemia or hypocalcaemia. Sevelamer does not contain calcium. Your doctor may monitor you for serum calcium levels as a normal follow up of a dialysis patient. Calcium supplements should be given in case of hypocalcaemia.
Metabolic disorders: patients are suffering from chronic kidney disorders are predisposed to developing metabolic acidosis. Worsening of metabolic acidosis have been reported upon switching from another phosphate binder to Foseal 400, where lower bicarbonate levels in the sevelamer treated patients compared to patients treated with calcium-based binders were reported.
Patients on peritoneal dialysis may develop peritonitis, an infection of your abdominal fluid associated with your peritoneal dialysis. However, one can reduce the risk by carefully adhering to the sterile methods during bag changes. In such cases, patients should inform their doctor immediately if they develop new signs of abdominal distress, abdominal pain, abdominal tenderness, swelling, constipation, abdominal rigidity, nausea, vomiting, fever, or chills. Your doctor may monitor you more carefully for problems with low levels of vitamins and folic acid.
There are reports of difficulty swallowing Foseal tablets. The drug’s safety and efficacy in children below the age of 18 years have not been studied.
Side effects of Foseal 400 mg
As mentioned above, constipation is common with Sevelamer usage, and it is especially important t inform your doctor of these symptoms before or during the treatment. Other side effects of the drug include nausea, vomiting, indigestion, diarrhoea, flatulence, hypersensitivity, and abdominal pain. If you develop any of these unwanted effects, talk to your doctor. By reporting adverse reactions, you can help provide more information on the safety of this drug.
What is Sevelamer and what condition does it treat?
Sevelamer is a phosphate binder medication used to control high phosphorus levels in people with chronic kidney disease who are on dialysis. Marketed under brand names like Foseal 400mg, this phosphate-lowering medicine helps prevent dangerous complications from hyperphosphatemia, including bone disease and cardiovascular problems. Unlike calcium-based binders, Sevelamer carbonate works without adding extra calcium to your system. Dialysis removes waste products but cannot fully eliminate excess phosphorus from blood, making phosphate binders essential for managing mineral balance in kidney failure patients requiring regular hemodialysis or peritoneal dialysis treatment.
How does Sevelamer work in the body?
Foseal 400mg contains Sevelamer, which binds to dietary phosphate in your digestive tract before it enters the bloodstream. This phosphate binder attaches to phosphorus from food you eat, forming compounds your body cannot absorb. The bound phosphorus then passes naturally through your intestines and exits in stool rather than accumulating in blood. Unlike older phosphate-lowering medications, Sevelamer is a non-metallic, non-absorbed polymer that stays entirely within your gastrointestinal system. This mechanism helps dialysis patients maintain healthier phosphorus levels without raising calcium, reducing risks of vascular calcification common with kidney disease treatment.
How long does Foseal 400mg take to work?
Foseal 400mg starts binding phosphate immediately during digestion, but noticeable reductions in blood phosphorus levels typically appear within two to four weeks of consistent use. Your nephrologist will monitor phosphate levels through regular blood tests to assess how effectively this phosphate binder is controlling hyperphosphatemia. The timeline varies based on your dietary phosphorus intake, dialysis schedule, and individual kidney function. Maximum phosphorus control with Sevelamer often requires dose adjustments over several weeks. Patience is important—kidney disease management involves gradual improvements rather than instant results, so continuing your prescribed regimen ensures optimal phosphate-lowering benefits.
When and how should I take Foseal 400mg?
Take Foseal 400mg with meals, typically three times daily alongside breakfast, lunch, and dinner. Swallow tablets whole with water—do not crush, chew, or break them, as this affects how the phosphate binder works. Taking Sevelamer with food is essential because it must be present in your stomach when dietary phosphorus arrives to bind effectively. Space doses evenly throughout the day for consistent phosphorus control. If you miss a dose, take it with your next meal rather than doubling up. Your healthcare provider will determine the right number of tablets per meal based on blood phosphorus levels and dietary habits.
Is Foseal 400mg safe for long-term use?
Foseal 400mg is specifically designed for ongoing use in chronic kidney disease patients requiring continuous phosphate management. Clinical studies demonstrate Sevelamer maintains safety and effectiveness over extended periods, often years, when used as directed for dialysis-related hyperphosphatemia. Unlike some phosphate binders that cause calcium accumulation over time, this non-calcium-based medication reduces long-term cardiovascular calcification risks. Your nephrologist will monitor vitamin levels, as phosphate binders can occasionally affect fat-soluble vitamin absorption. Regular blood work ensures the medicine continues working optimally without complications. Most kidney patients remain on phosphate-lowering therapy throughout their dialysis journey.
Can I take Foseal 400mg with other medicines?
Foseal 400mg can interact with certain medications by binding them in your digestive system, reducing their absorption. Take other oral medicines at least one hour before or three hours after your Sevelamer dose to avoid interactions. Particularly affected medications include thyroid hormones, seizure medications, immunosuppressants, and some antibiotics. Always inform your nephrologist and pharmacist about all prescriptions, supplements, and over-the-counter products you use. Many dialysis patients successfully combine this phosphate binder with kidney disease medications, blood pressure treatments, and vitamins when properly timed. Your healthcare team will create a medication schedule optimizing both phosphate control and your other therapies.
How does Foseal 400mg compare to similar medicines in its class?
Foseal 400mg belongs to the non-calcium phosphate binder category alongside Sevelamer-based products like Renagel and Renvela. Compared to older calcium-based binders such as calcium acetate, Sevelamer offers advantages in preventing vascular calcification and calcium overload in dialysis patients. It also reduces LDL cholesterol slightly, unlike metal-based alternatives. Lanthanum and iron-based phosphate binders work differently but serve the same phosphorus-lowering purpose. Foseal provides the proven benefits of Sevelamer carbonate formulation at competitive pricing. Your nephrologist chooses phosphate binder therapy based on your calcium levels, cardiovascular risk, tolerability, and treatment goals for managing chronic kidney disease.
Is generic Sevelamer as effective as branded versions?
Generic Sevelamer products like Foseal 400mg contain the identical active ingredient and meet the same regulatory standards as branded versions such as Renvela. Pharmaceutical authorities in the USA, UK, Canada, and Australia require generic phosphate binders to demonstrate bioequivalence—meaning they work identically in your body. The phosphorus-lowering effectiveness, safety profile, and dosing remain unchanged between generic and brand-name Sevelamer formulations. Many nephrologists and dialysis patients successfully use generics for hyperphosphatemia management, appreciating the cost savings without sacrificing kidney disease treatment quality. Clinical outcomes depend on consistent use and proper dosing rather than whether you choose generic or branded phosphate binder medication.
Why do patients choose PremiumRxDrugs for Foseal 400mg?
Dialysis patients select PremiumRxDrugs for Foseal 400mg because of reliable access to authentic phosphate binder medication at competitive pricing. The pharmacy's decade-plus reputation, licensing credentials, and manufacturer-sourced Sevelamer products provide peace of mind for chronic kidney disease management. Convenient features include easy prescription uploads, straightforward reordering systems for ongoing therapy, and discreet packaging respecting patient privacy. International shipping reaches customers across the USA, UK, Canada, Australia, and beyond, with free shipping options available. For patients managing hyperphosphatemia long-term, combining quality assurance with affordability and convenience makes PremiumRxDrugs a practical choice for maintaining consistent phosphorus control.
What are the common side effects of Sevelamer?
Common side effects of Sevelamer include digestive issues such as nausea, vomiting, diarrhea, constipation, and stomach pain. These gastrointestinal effects occur because the phosphate binder works directly in your digestive tract. Many patients experience gas, bloating, or indigestion, particularly when starting treatment. These symptoms often improve as your body adjusts to the medication. Less common reactions include headache or itching. Serious side effects like severe constipation or bowel obstruction are rare but require immediate medical attention. Most dialysis patients tolerate this phosphate-lowering medicine well when taken with meals as directed. Persistent or bothersome symptoms warrant discussion with your nephrologist about dosage adjustments.
Who should avoid taking Sevelamer?
People with bowel obstruction or severely reduced gut motility should not take Sevelamer, as this phosphate binder can worsen digestive blockages. Those with a history of major gastrointestinal surgery, swallowing difficulties, or severe constipation require careful evaluation before starting treatment. Patients with low phosphorus levels should avoid phosphate-lowering medications, as further reduction causes dangerous complications. Individuals allergic to Sevelamer or medication components should not use this therapy. Pregnant or breastfeeding women need medical guidance, as research in these populations remains limited. Your nephrologist will assess your complete medical history, current digestive health, and kidney disease status before prescribing this phosphate binder.
Login
Sign Up
Login
Sign Up